HC Wainwright Reiterates “Buy” Rating for TG Therapeutics (NASDAQ:TGTX)
TG Therapeutics (NASDAQ:TGTX – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $55.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 56.65% from the stock’s current price. HC Wainwright […]
TG Therapeutics (NASDAQ:TGTX – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $55.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 56.65% from the stock’s current price. HC Wainwright […]
